Therefore, it is suggested that PPAR-γ activation and COX-2 inhibition serve as two signaling pathways for the inhibitory effects of ALA in RCC cell proliferation, and that these two signaling pathways are parallel in the route map. This evidence concerns the gene PPARG and renal cell carcinoma.